Gadoxetic acid-based hepatobiliary MRI in hepatocellular carcinoma

Gadoxetic acid-based hepatobiliary MRI in hepatocellular carcinoma

Background & Aims: SORAMIC is a prospective phase II randomised controlled trial in hepatocellular carcinoma (HCC). It consists of 3 parts: a diagnostic study and 2 therapeutic studies with either curative ablation or palliative Yttrium-90 radioembolisation combined with sorafenib. We report...

Full description

Bibliographic Details
Main Authors: Jens Ricke, Ingo G. Steffen, Irene Bargellini, Thomas Berg, José Ignacio Bilbao Jaureguizar, Bernhard Gebauer, Roberto Iezzi, Christian Loewe, Musturay Karçaaltincaba, Maciej Pech, Christian Sengel, Otto van Delden, Vincent Vandecaveye, Christoph J. Zech, Max Seidensticker
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:JHEP Reports
Subjects:
Gadoxetic acid
Hepatocellular carcinoma
Magnetic resonance imaging
SORAMIC trial
Online Access:http://www.sciencedirect.com/science/article/pii/S2589555920301075

Internet

http://www.sciencedirect.com/science/article/pii/S2589555920301075

Similar Items